IVIvana Vitkova

Ivana Vitkova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ivana Vitkova has a total of 134 co-authors. Here are the top co-authors by number of shared publications:

  • Ales Linhart

    2nd Department of Internal Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital , Prague

    10 shared publications
  • Petr Kuchynka

    2nd Department of Medicine, Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague , Prague

    9 shared publications
  • Tomas Palecek

    2nd Department of Medicine – Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital , U nemocnice 2, Prague 2, 128 02 , Czech Republic

    8 shared publications
  • Eduard Nemecek

    2nd Department of Medicine - Department of Cardiovascular Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic

    5 shared publications
  • Jaroslav Lindner

    2nd Department of Surgery, Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital, 128 08 Prague, Czech Republic

    5 shared publications
  • Pavel Kopecký

    Medical Faculty, Charles University, Prague, Czech Republic

    5 shared publications

Latest Publications

  • Papillary fibroelastoma originating from the free left ventricular wall as the cause of recurrent stroke: Description of the case and literature review

    by OndřEj Macura, Tomáš Paleček, Jaroslav Hlubocký, Petr Vondráček, Ivana Vítková, Jan Kuchař, Zuzana Hlubocká


  • Open Access

    Absence of Borrelia burgdorferi in the myocardium of subjects with normal left ventricular systolic function: a study using PCR and electron microscopy

    by Petr Kuchynka, Tomas Palecek, Tomas Grus, Jaroslav Lindner, Dagmar Berenova, Zuzana Kurzova, Pavla Balatova, Daniel Krsek, Ivana Vitkova, Eduard Nemecek, et al.

    Several studies have demonstrated the presence of the Borrelia burgdorferi (Bb) genome in the myocardium of patients with dilated cardiomyopathy (DCM). To further support a causal relationship between the presence of Bb in the heart muscle and the development of DCM, demonstration of the absence of Bb in the myocardium of subjects with normal left ventricular (LV) systolic function is needed. To determine the prevalence of Bb by polymerase chain reaction (PCR) and electron microscopy (EM) in individuals with normal LV systolic function and no history suggestive of myocarditis. We investigated 50 patients (67 ± 9 years, 15 women) with normal LV ejection fraction (EF) ≥ 50% undergoing cardiac surgery. During surgery, four samples from the right atrial appendage were obtained and subsequently examined by PCR and EM for the presence of Bb, and by immunohistochemistry to detect inflammatory cells. Serological testing of antibodies against Bb was also performed. Neither PCR nor EM detected Bb in any of the subjects. Immunohistological examination revealed myocardial inflammation in 2 individuals (4%). Serological analysis by enzyme-linked immunosorbent assay demonstrated IgM antibodies against Bb in 4% and IgG antibodies in 12% of the study cohort; Western blot revealed IgM as well as IgG positivity in 14% of patients. The absence of Bb in the myocardium of individuals who undergo cardiac surgery and have normal LV systolic function supports the idea of Bb pathogenicity in the development of DCM.


  • Open Access

    Current Diagnostic and Therapeutic Aspects of Eosinophilic Myocarditis

    by Petr Kuchynka, Tomas Palecek, Martin Masek, Vladimir Cerny, Lukas Lambert, Ivana Vitkova, Ales Linhart

    Eosinophilic myocarditis (EM) represents a rare form of myocardial inflammation with very heterogeneous aetiology. In developed countries, the most prevalent causes of EM are hypersensitivity or allergic reactions, as well as hematological diseases leading to eosinophilia. The disease may have a variable clinical presentation, ranging from asymptomatic forms to life-threatening conditions. Most patients with EM have marked eosinophilia in peripheral blood. Endomyocardial biopsy needs to be performed in most cases in order to establish a definitive diagnosis of EM. The therapy depends on the underlying aetiology. Immunosuppressive therapy represents the treatment mainstay in the majority of EM forms.


  • A rare case of regressively changed lipomatous hypertrophy of the interatrial septum presenting with anemia and recurrent fever

    by Daniel Rob, Petr Kuchynka, Tomas Palecek, Vladimir Cerny, Martin Masek, Ivana Vitkova, Zuzana Rucklova, Eduard Nemecek, David Zogala, Ales Linhart


  • A high frequency of viral agents yet absence of Borrelia burgdorferi is seen within the myocardium of subjects with normal left ventricular systolic function: an electron microscopy study

    by Petr Kuchynka, Tomas Palecek, Tomas Grus, Jana Schramlova, Daniel Krsek, Ivana Vitkova, Vilem Rohn, Jaroslav Lindner, Eleanor Wicks, Eduard Nemecek, et al.

    A wide range of viral agents is associated with the development of acute myocarditis and its possible chronic sequela, dilated cardiomyopathy (DCM). There is also increasing evidence that Borrelia burgdorferi (Bb) is associated with DCM in endemic regions for Bb infection. This study sought to use electron microscopy to prospectively analyze the presence of viruses and Bb within the myocardium of 40 subjects with preserved left ventricular (LV) ejection fraction and 40 patients with new-onset unexplained DCM during the same time period. Virus particles were found within the myocardium of 23 subjects (58 %) of both cohorts studied, yet there was no statistically significant difference in virus family presence between those with DCM versus those with preserved LV systolic function. In contrast, Bb was detected only in those subjects with DCM (0 versus 5 subjects; p ˂ 0.05). Polymerase chain reaction was performed on samples from patients who were positive for Bb according to electron microscopy, and Bb was confirmed in 4 out of 5 individuals. Our results demonstrate that the prevalence of viral particles does not differ between subjects with preserved LV systolic function versus those with DCM and therefore suggests that the mere presence of a viral agent within the myocardium is not sufficient to establish a clear link with the development of DCM. In contrast, the presence of Bb was found only within myocardial samples of patients with DCM; this finding supports the idea of a causal relationship between Bb infection and DCM development.


  • Recent-onset dilated cardiomyopathy associated with Borrelia burgdorferi infection

    by Petr Kuchynka, Tomas Palecek, Stepan Havranek, Ivana Vitkova, Eduard Nemecek, Radka Trckova, Dagmar Berenová, Daniel Krsek, Jana Podzimkova, Michal Fikrle, et al.

    Several recent small studies have suggested a causal link between Lyme disease and dilated cardiomyopathy (DCM) by demonstrating the presence of the Borrelia burgdorferi (Bb) genome in the myocardium of patients with recent-onset DCM. The aim of this study was to further investigate the effect of targeted antibiotic treatment of Bb-related recent-onset DCM in a larger cohort of patients. We performed endomyocardial biopsy (EMB) in 110 individuals (53 ± 11 years, 34 women) with recent-onset unexplained DCM, and detected the Bb genome in 22 (20 %) subjects. Bb-positive patients were subsequently treated with intravenous ceftriaxone for 21 days in addition to conventional heart failure medication. At the 1-year follow-up, a significant improvement in left ventricular (LV) ejection fraction (26 ± 6 vs. 44 ± 12 %; p < 0.01) and a decrease in LV end-diastolic (69 ± 7 vs. 63 ± 11 mm; p < 0.01) and end-systolic (61 ± 9 vs. 52 ± 4 mm; p < 0.01) diameters were documented. Moreover, a significant improvement in heart failure symptoms (NYHA class 3.4 ± 0.6 vs. 1.5 ± 0.7; p < 0.01) was also observed. Targeted antibiotic treatment of Bb-related recent-onset DCM in addition to conventional heart failure therapy is associated with favorable cardiac remodeling and improvement of heart failure symptoms. Verschiedenen aktuellen kleinen Studien zufolge könnte ein ursächlicher Zusammenhang zwischen der Lyme-Borreliose und der dilatativen Kardiomyopathie (DCM) bestehen, denn es wurde das Vorliegen des Borrelia-burgdorferi(Bb)-Genoms im Myokard von Patienten mit seit Kurzem bestehender DCM nachgewiesen. Ziel der vorliegenden Studie war es, die Wirksamkeit gezielter antibiotischer Behandlung der neu aufgetretenen Bb-DCM in einer großen Patientenkohorte näher zu untersuchen. Die Autoren führten Endomyokardbiopsien (EMB) bei 110 Personen (53 ± 11 Jahre, 34 Frauen) mit seit Kurzem bestehender DCM unklarer Genese durch und fanden das Bb-Genom bei 22 (20 %) Personen. Die Bb-positiven Patienten wurden daraufhin zusätzlich zur konventionellen medikamentösen Therapie gegen Herzinsuffizienz mit Ceftriaxon i.v. über 21 Tage behandelt. Nach einer Nachbeobachtungsphase von einem Jahr wurden eine signifikante Verbesserung der linksventrikulären (LV-)Ejektionsfraktion (26 ± 6 vs. 44 ± 12 %; p < 0,01) und eine Abnahme des LV enddiastolischen (69 ± 7 vs. 63 ± 11 mm; p < 0,01) und endsystolischen (61 ± 9 vs. 52 ± 4 mm; p < 0,01) Durchmessers dokumentiert. Außerdem wurde auch eine signifikante Linderung der Herzinsuffizienzsymptome (NYHA-Klasse 3,4 ± 0,6 vs.1,5 ± 0,7; p < 0,01) festgestellt. Die gezielte antibiotische Behandlung der neu aufgetretenen Bb-DCM zusätzlich zur konventionellen Therapie gegen Herzinsuffizienz geht mit günstigem kardialem Remodeling und Linderung der Herzinsuffizienzsymptome einher.


  • Open Access

    Arrhythmogenic substrate at the interventricular septum as a target site for radiofrequency catheter ablation of recurrent ventricular tachycardia in left dominant arrhythmogenic cardiomyopathy

    by Stepan Havranek, Tomas Palecek, Tomas Kovarnik, Ivana Vitkova, Miroslav Psenicka, Ales Linhart, Dan Wichterle

    Left dominant arrhythmogenic cardiomyopathy (LDAC) is a rare condition characterised by progressive fibrofatty replacement of the myocardium of the left ventricle (LV) in combination with ventricular arrhythmias of LV origin. A thirty-five-year-old male was referred for evaluation of recurrent sustained monomorphic ventricular tachycardia (VT) of 200 bpm and right bundle branch block (RBBB) morphology. Cardiac magnetic resonance imaging showed late gadolinium enhancement distributed circumferentially in the epicardial layer of the LV free wall myocardium including the rightward portion of the interventricular septum (IVS). The clinical RBBB VT was reproduced during the EP study. Ablation at an LV septum site with absence of abnormal electrograms and a suboptimum pacemap rendered the VT of clinical morphology noninducible. Three other VTs, all of left bundle branch block (LBBB) pattern, were induced by programmed electrical stimulation. The regions corresponding to abnormal electrograms were identified and ablated at the mid-to-apical RV septum and the anteroseptal portion of the right ventricular outflow tract. No abnormalities were found at the RV free wall including the inferolateral peritricuspid annulus region. Histological examination confirmed the presence of abnormal fibrous and adipose tissue with myocyte reduction in endomyocardial samples taken from both the left and right aspects of the IVS. LDAC rarely manifests with sustained monomorphic ventricular tachycardia. In this case, several VTs of both RBBB and LBBB morphology were amenable to endocardial radiofrequency catheter ablation.


  • Open Access

    High frequency of various viral agents and absence of Borrelia burgdorferi in the myocardium of subjects with normal left ventricular systolic function

    by P. Kuchynka, T. Palecek, E. Nemecek, G. Dostalova, T. Grus, V. Rohn, J. Lindner, J. Schramlova, I. Vitkova, A. Linhart

    Introduction: Inflammatory cardiomyopathy (DCMi) is a term used for systolic dysfunction of the Left Ventricle (LV) associated with persistent inflammation of the myocardium. Endomyocardial Biopsy (EMB) with an evidence of myocardial infection and /or inflammation is considered as the gold standard in the diagnosis of DCMi. However, recent studies using PCR methodology showed the presence of the viral genome (parvovirus B19 in particular) in individuals with normal LV systolic function. So far, there are no data about the presence of Borrelia burgdorferi (Bb), another potential pathogen of DCMi, in the myocardium of subjects with normal LV systolic function. Aim of the study: To determine the prevalence of viral agents and Bb in individuals with normal LV systolic function and no history suggestive of DCMi by electron microscopy. Methods: We investigated 38 patients (67±7 years, 6 women) with normal EF undergoing myocardial revascularization and/or heart valve surgery. During the surgery procedure we obtained samples of the right atrial appendage which were subsequently examined by electron microscopy for the presence of viral agents and Bb and by immunohistochemistry to detect inflammatory cells. Results: Viral agents were found in 25 subjects (66% of the study group) Herpesviridae family viral presence was detected in 34% of the studied subjects, Picornaviruses in 26%, a virus belonging to the Parvoviridae family in 13% and a member of the Paramyxoviridae in 3%. On the other hand, Bb was not detected in any case. Immunohistological examination did not demonstrate myocardial inflammation in any of the study subjects. Conclusions: The high prevalence of various viral agents in the myocardium of subjects with normal LV systolic function and the absence of immunohistological markers of myocardial inflammation proves that mere presence of viruses within the myocardium cannot be put into direct causal relationship with the development of DCMi. On the contrary, the absence of Bb in these individuals supports the idea of Bb pathogenicity in relation to development of the LV systolic dysfunction. The research project has been supported by the Czech Society of Cardiology.

  • A case of an epignathus with intracranial extension appearing as a persistently open mouth at 16 weeks and subsequently diagnosed at 20 weeks of gestation

    by Pavel Calda, Michaela Novotná, David Čutka, Miroslav Břešt'ák, Lubomír Hašlík, Barbara Goldová, Ivana Vítková, Manuela Vaněčková, Zdeněk Seidl

    We report a rare case of oral mass (epignathus) with intracranial extension originally suspected antenatally at 16 weeks' gestation because of a persistent open mouth. Postmortem MRI and pathologic examination of the fetus confirmed an oral teratoma with bilateral ventricular dilatation, corpus callosum agenesis, and a neuroepithelial intracranial cyst. The relevant literature regarding this anomaly is reviewed. © 2010 Wiley Periodicals, Inc. J Clin Ultrasound, 2011